Amivantamab and Lazertinib
About
Membership operator: AND
Therapies: 2
Therapies
Amivantamab (tx:ncit:C124993)
Lazertinib (tx:ncit:C148147)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy group.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| EMA (3) FDA (4) | EGFR Exon 19 (Deletion) | Non-Small Cell Lung Cancer | Amivantamab, Lazertinib | |
| EMA (3) FDA (4) | EGFR p.L858R | Non-Small Cell Lung Cancer | Amivantamab, Lazertinib |